Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease skin disease
Phenotype C0042109|urticaria
Sentences 6
PubMedID- 21841304 Chronic urticaria is one of the most frequent skin diseases in medical practice.
PubMedID- 20687621 Numerous short- and long-term clinical trials and surveillance studies have shown that twice-daily bepotastine is an effective and generally well tolerated antihistamine in the treatment of patients with allergic rhinitis, chronic urticaria or pruritus associated with skin conditions (eczema/dermatitis, prurigo or pruritus cutaneus).
PubMedID- 24105252 Background and objective: bepotastine is a second-generation histamine h(1) receptor antagonist that is indicated in allergic rhinitis, urticaria, and pruritus associated with skin disease.
PubMedID- 24236825 Background: although urticaria is considered one of the most frequent skin diseases, reliable epidemiologic data are scarce.
PubMedID- 24656153 Background: bepotastine is a second-generation histamine1 receptor antagonist that is used in the treatment of allergic rhinitis, urticaria, and pruritus associated with skin disease.
PubMedID- 24191914 Oral bepotastine is a safe and effective treatment option approved in japan for allergic rhinitis, urticaria and pruritus associated with skin diseases.

Page: 1